Advanced Breast Cancer Clinical Trials in Guangzhou, Guangdong
10 recruitingGuangzhou, Guangdong, China
Showing 1–10 of 10 trials
Recruiting
Phase 3
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
HER2-positive Advanced Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.416 enrolled75 locationsNCT07047365
Recruiting
Phase 1
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Metastatic Breast CancerHER2-negative Breast CancerAdvanced Solid Tumor+6 more
BeOne Medicines399 enrolled63 locationsNCT06120283
Recruiting
Phase 1Phase 2
A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.
Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer Stage IV+1 more
Forward Pharmaceuticals Co., Ltd.99 enrolled22 locationsNCT06064812
Recruiting
Phase 3
A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
Metastatic Breast CancerLocally Advanced Breast Cancer
Shandong Suncadia Medicine Co., Ltd.240 enrolled2 locationsNCT07024173
Recruiting
Phase 2
Efficacy and Safety of Trastuzumab Rezetecan Followed by CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2-Low/Ultra-Low Advanced Breast Cancer
Advanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University45 enrolled1 locationNCT07037199
Recruiting
Phase 3
Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer
Fludzoparib" and Anti-angiogenicHRD-positive/HER2-negative Advanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University200 enrolled1 locationNCT06255392
Recruiting
Phase 1
Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer
Advanced Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.32 enrolled2 locationsNCT06710990
Recruiting
Phase 2
Organoid-based Functional Precision Therapy for Advanced Breast Cancer
HER2-negative Breast CancerAdvanced Breast Cancer
Guangdong Provincial People's Hospital252 enrolled1 locationNCT06102824
Recruiting
Phase 1Phase 2
HCQ+ADC vs ADC in the Treatment of Advanced Breast Cancer
Metastatic Breast CancerAdvanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University120 enrolled1 locationNCT06328387
Recruiting
Phase 1Phase 2
Plasmodium Immunotherapy for Breast and Liver Cancers
Advanced Breast CancerAdvanced Liver Cancer
CAS Lamvac Biotech Co., Ltd.60 enrolled1 locationNCT03474822